Jeena Sikho Lifecare Ltd
JSLLJeena Sikho Lifecare Ltd
JSLLHealth CarePharmaceuticals
SmallcapWith a market cap of ₹2,945 cr, stock is ranked 884
High RiskStock is 6.05x as volatile as Nifty
1,179.550.45% (-5.35)
1,179.550.45% (-5.35)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 23.42 | 0.35% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
43.83 | 5.97 | 0.59% |
Forecast & Ratings
Detailed Forecast—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Jeena Sikho Lifecare is engaged in developing health care products and providing ayurvedic healthcare services in India.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
43.36
1Y Return
63.62%
Buy Reco %
80.00
Cipla Ltd
PE Ratio
27.41
1Y Return
51.42%
Buy Reco %
67.74
Zydus Lifesciences Ltd
PE Ratio
27.41
1Y Return
94.49%
Buy Reco %
42.31
Dr Reddy's Laboratories Ltd
PE Ratio
17.31
1Y Return
29.41%
Buy Reco %
36.36
Torrent Pharmaceuticals Ltd
PE Ratio
73.35
1Y Return
62.96%
Buy Reco %
76.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Earnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 105.88 | 95.17 | 136.87 | 148.04 | 207.35 | 330.85 | — | |||||||
Raw Materials | 95.21 | 83.88 | 118.93 | 12.64 | 16.43 | 231.42 | — | |||||||
Power & Fuel Cost | 1.08 | 2.38 | ||||||||||||
Employee Cost | 33.80 | 44.05 | ||||||||||||
Selling & Administrative Expenses | 75.01 | 82.76 | ||||||||||||
Operating & Other expenses | 5.92 | 13.28 | ||||||||||||
EBITDA | 10.67 | 11.29 | 17.94 | 19.59 | 48.45 | 99.43 | — | |||||||
Depreciation/Amortization | 1.21 | 1.94 | 2.46 | 3.31 | 3.20 | 5.10 | — | |||||||
PBIT | 9.46 | 9.35 | 15.48 | 16.28 | 45.25 | 94.33 | — | |||||||
Interest & Other Items | 1.13 | 1.64 | 1.30 | 1.18 | 0.95 | 0.41 | — | |||||||
PBT | 8.33 | 7.71 | 14.18 | 15.10 | 44.30 | 93.92 | — | |||||||
Taxes & Other Items | 2.33 | 1.99 | 3.89 | 3.85 | 10.51 | 24.71 | — | |||||||
Net Income | 6.00 | 5.72 | 10.29 | 11.25 | 33.79 | 69.21 | — | |||||||
EPS | 599.71 | 572.63 | 10.19 | 4.42 | 11.73 | 27.84 | — | |||||||
DPS | — | — | — | 0.00 | 1.11 | 4.18 | — | |||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.15 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticalsCompare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Jeena Sikho Lifecare Ltd | 42.56 | 23.42 | 0.35% |
Sun Pharmaceutical Industries Ltd | 43.36 | 6.19 | 0.75% |
Cipla Ltd | 27.41 | 4.76 | 0.93% |
Zydus Lifesciences Ltd | 27.41 | 5.37 | 0.29% |
Price Comparison
Compare JSLL with any stock or ETFCompare JSLL with any stock or ETF
JSLL
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2023
Sep 2023
Nov 2023
Mar 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 25, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 25, 2023
News & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant